Reducing Reintubation Risk in High-Risk Cardiac Surgery Patients With High-Flow Nasal Cannula

NARecruitingINTERVENTIONAL
Enrollment

3,400

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

November 1, 2025

Study Completion Date

December 1, 2025

Conditions
IntubationCardiovascular Surgical Procedure
Interventions
OTHER

Recommendation for high flow nasal cannula oxygen therapy order set

Participants will be assigned post extubation physician order set which recommends the administration of oxygen therapy via HFNC. HFNC is a heated and humidified system that allows prescribed fraction of inspired oxygen (FIO2) levels to be delivered at very high flow rates.

OTHER

Provider choice standard care order set

Participants will receive order set with provider choice of standard care therapy.

Trial Locations (1)

37212

RECRUITING

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Vanderbilt University Medical Center

OTHER